Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
Open Access
- 14 December 2012
- journal article
- review article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 11 (1), 418
- https://doi.org/10.1186/1475-2875-11-418
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Primaquine to prevent transmission of falciparum malariaThe Lancet Infectious Diseases, 2013
- Primaquine for reducingPlasmodium falciparumtransmissionPublished by Wiley ,2012
- Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal studyThe Lancet, 2012
- Epidemiology and Infectivity of Plasmodium falciparum and Plasmodium vivax Gametocytes in Relation to Malaria Control and EliminationClinical Microbiology Reviews, 2011
- Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trialThe Lancet Infectious Diseases, 2010
- In Tanzania, Hemolysis after a Single Dose of Primaquine Coadministered with an Artemisinin Is Not Restricted to Glucose-6-Phosphate Dehydrogenase-Deficient (G6PD A−) IndividualsAntimicrobial Agents and Chemotherapy, 2010
- Artemisinin Resistance inPlasmodium falciparumMalariaThe New England Journal of Medicine, 2009
- Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicityMalaria Journal, 2008
- Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trialsMalaria Journal, 2008
- Transmission-Blocking Activities of Quinine, Primaquine, and ArtesunateAntimicrobial Agents and Chemotherapy, 2006